(Q28377976)

5

0 references

Andrzej Pilc

object named as

A Pilc

6

0 references

author name string

A Kłodzińska

1

0 references

E Chojnacka-Wójcik

2

0 references

A Pałucha

Evaluation of a rapid technique for detecting minor tranquilizers

3

0 references

language of work or name

English

0 references

publication date

December 1999

0 references

published in

Neuropharmacology

0 references

volume

38

0 references

page(s)

1831-9

0 references

issue

12

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

A novel orally active group 2 metabotropic glutamate receptor agonist: LY354740.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Excitatory amino acid receptor antagonists and naloxone-precipitated withdrawal syndrome in morphine-dependent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Pharmacology and functions of metabotropic glutamate receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Attenuation of precipitated morphine withdrawal symptoms by acute i.c.v. administration of a group II mGluR agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Attenuation of morphine withdrawal symptoms by subtype-selective metabotropic glutamate receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

The effects of repeated administration of diazepam, MK-801 and CGP 37849 on rat behavior in two models of anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Metabotropic glutamate receptor-mediated presynaptic depression at corticostriatal synapses involves mGLuR2 or 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Pharmacology of metabotropic glutamate receptors at the mossy fiber synapses of the guinea pig hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

1-Aminocyclopropane carboxylic acid: a potent and selective ligand for the glycine modulatory site of the N-methyl-D-aspartate receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Design, synthesis, and pharmacological characterization of (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxioly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

The metabotropic glutamate receptors: structure and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Effects of drugs on punished behavior: pre-clinical test for anxiolytics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Anticonflict effect of ipsapirone, buspirone and gepirone is not mediated by their common metabolite 1-(2-pyrimidinyl)piperazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Antidepressant-like effects of a partial agonist at strychnine-insensitive glycine receptors and a competitive NMDA receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Water intake induced in rats by serotonin and 5-hydroxytryptophan: different mechanisms?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Inhibition of Cyclic AMP Formation by a Selective Metabotropic Glutamate Receptor Agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

A glutamatergic hypothesis of drug dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

The tail suspension test: a new method for screening antidepressants in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Metabotropic glutamate group II receptors are responsible for the depression of synaptic transmission induced by ACPD in the dentate gyrus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

A simple and reliable conflict procedure for testing anti-anxiety agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0

Modulation of glutamate receptors: molecular mechanisms and functional implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2899%2900066-0